Daily Market Briefing

2026-10-15 · Money Checkup market briefing

# Small Caps Lead as Biotech Stocks Surge; FMC Plunges 30% on Likely Earnings Miss

The Russell 2000 outpaced the broader market today, gaining 1.38% to 2767.27, while the S&P 500 and Nasdaq posted much more muted gains of 0.33% and 0.08% respectively. The outperformance from smaller stocks reflects a sharp divergence in today's trading: biotech and pharmaceutical names accelerated sharply higher, while energy, materials, and leasing stocks sold off hard. The day's most striking move came in chemicals giant **FMC Corp (FMC)**, which crashed 30.5%—a magnitude of loss that typically signals an earnings miss, guidance cut, or major operational issue.

Biotech and pharma dominated today's gainers list, with five of the top eight stocks coming from that sector. **Indaptus Therapeutics (INDP)** rallied 29.0%, **Akari Therapeutics (AKTX)** jumped 21.4%, and **Neumora Therapeutics (NMRA)** gained 20.3%, part of a broader lift across the space. The broader Biotechnology: Laboratory Analytical Instruments industry group posted a +19.0% gain across 11 companies, including names like Agilent Technologies and Waters Corp. Meanwhile, **Triller Group (ILLR)**, a consumer/media name, led all gainers with a stunning +33.9%, and **OPKO Health (OPK)**, a diversified healthcare play, rose 17.5%. The momentum in healthcare—both therapeutics and equipment—appears to have overwhelmed headwinds elsewhere.

That said, weakness was equally pronounced in cyclical and commodities-linked sectors. **FMC's 30.5% collapse** was the session's most dramatic loser, but it wasn't alone. Oilfield Services and Equipment names fell 13.1% as a group, dragging down heavyweights like Halliburton and Schlumberger. Aluminum stocks tumbled 13.3%, while Blank Check companies (SPACs) lost 19.4%. Insurance and staffing also felt pressure: **ManpowerGroup (MAN)** fell 15.8%, and **Aspen Insurance Preferred (AHL-PD)** sank 17.6%. The Misc Corporate Leasing Services group, which includes aircraft leasing firms like FTAI Aviation, dropped 12.8%.

On the filing front, several major retailers and tech names filed their 2026 annual reports this week. **Costco (COST)** posted a 10-K on October 7th with a Health Score of 47.7—a middle-of-the-road reading that reflects solid operations but room for improvement in balance sheet or profitability metrics. **Village Super Market (VLGEA)** came in stronger at 69.8, while **Copart (CPRT)**, the auto-auction specialist, filed with a 66.7 score. Meanwhile, **Micron Technology (MU)** filed on October 9th but carries a concerning Health Score of just 31.5, suggesting the memory-chip maker faces headwinds in profitability or leverage. Separately, five companies remain flagged with going-concern audit notes—**Entrada Therapeutics (TRDA)**, **FS KKR Capital (FSK)**, **Bain Capital Specialty Finance (BCSF)**, **New Mountain Finance (NMFC)**, and **Innovative Industrial Properties (IIPR)**—meaning auditors have expressed substantial doubt about their ability to continue operating. These names warrant close monitoring.

The day's divergence between biotech strength and energy/materials weakness underscores a rotation into defensive and growth-oriented healthcare, while cyclical and commodity-exposed sectors face near-term headwinds. For value and quality-focused investors, today's filing data and going-concern flags offer useful screens to filter risk.